Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women
Clinical trial NCT02651259 · COMPLETED
Trial details
- NCT number
- NCT02651259
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2019-04-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.